alexa Phytochemical Profiling And Quality Control Of Hypoxis Raw Materials And Products By RP-UPLCMS And HPTLC
ISSN: 2329-6836

Natural Products Chemistry & Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference and Exhibition on Pharmacognosy, Phytochemistry & Natural Products
August 25-27, 2014 DoubleTree by Hilton Beijing, China

Bassey K N, Combrinck and S Viljoen A M
Accepted Abstracts: Nat Prod Chem Res
DOI: 10.4172/2329-6836.S1.005
Abstract
Hypoxis hemerocallidea (Hypoxidaceae) is a traditional medicinal plant widely used in Southern Africa. The pharmacological properties of commercial products from Hypoxis against diseases like benign hypertrophy (BHP) are associated to rooperol, the aglycone of hypoxoside is the major phytoconstituent of the Hypoxis genus. Sterol(in)s are the other compounds responsible for anticancer and immune boosting properties of this plant. Several Hypoxis species are hitherto identified only on the basis of morphology and similarities thereof has led to interchangeable use of different species for the treatment of the same disease by traditional healers (sangomas). Although it was qualitatively postulated from HPLC analysis that flavanoids, triterpens and so forth are present in Hypoxis hemerocallidea, there is only one chemical profiled, that indicated the cooccurrence of hypoxoside, dehydroxy hypoxoside and bis-dehydroxy hypoxoside in Hypoxis hemerocallidea. We investigated the chemical profiles of 8 medicinal Hypoxis (n=105) species and the quality of 14 commercial products using RP-UPLC-MS and HPTLC in an attempt to redress the impending problem of unsafe and low quality products. Results obtained indicated that 6 other secondary metabolites (orcinol A glucoside, curculigoside, curculigoside C, apiofuranosyl curculigoside, arueaside B and stigmasterolin) are present between 0.00 to 5.00% mg-1 dw plant material. Out of 14 commercial products with hypoxosdie and/or sterol(ins) on their labels, only 3 contained hypoxoside and/or stigmasterolin between 0.02% to 3.12% mg-1dw. A through scrutiny and validated quality control protocols is indispensable to regulate the numerous commercial products of Hypoxis that floods both the Southern Africa and international markets.
Biography
Bassey K N is at the final stage of submitting his PhD thesis for a pharmaceutical sciences degree. He obtained his Master degree in chemistry (organic synthesis) at the age of 36 years from Tshwane University of Technology. He presented at the 11th Frank Warren and 2013 Indigenous Plant Use Forum (IPUF). He has about 5 articles under review for publications.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords